COMMUNIQUÉS West-GlobeNewswire

SMISS Asia Pacific 2024 Congress and training program
26/06/2024
Press release Ecully, June 26, 2024 – 6 p.m. Hands-on surgical training in Hong Kong at the SMISS Asia Pacific 2024 Congress The Spineway Group, a specialist in innovative implants for the treatment of severe spine [...]
Congrès Asie Pacifique SMISS 2024 et programme de formation
26/06/2024
Communiqué de presse Ecully, le 26 juin 2024 – 18h Formations pratiques chirurgicales à Hong Kong lors du congrès SMISS Asia Pacific 2024 Le groupe Spineway spécialiste des implants innovants pour le traitement des [...]
Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board
26/06/2024
Saint-Herblain (France), June 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the [...]
Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale et la nomination d’un nouvel administrateur à son conseil d’administration
26/06/2024
Saint-Herblain (France), le 26 juin 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que toutes les résolutions recommandées par son conseil d’ [...]
EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth1
26/06/2024
Press Release Agreement with Sanofi on a 200 M€ investment through a Perpetual Subordinated Hybrid Bond, upon the completion of the ongoing discussions to amend and extend the current Revolving Credit Facility 75 to 80 [...]
EUROAPI poursuit sa transformation grâce au plan FOCUS-27 et pose les bases d’une future croissance rentable1
26/06/2024
Communiqué de presse Accord avec Sanofi pour un investissement de 200 millions d’euros via une obligation Hybride Subordonnée à Durée Indéterminée, à l'issue des discussions en cours destinées à amender et à étendre le [...]
Allergy Named Highest-Impact Journal in Allergy and Clinical Immunology for 2024
26/06/2024
ZURICH, Switzerland, June 26, 2024 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI) is thrilled to announce that Allergy , one of EAACI’s official journals, has been recognised as the [...]
CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change
26/06/2024
HOUSTON, June 26, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is thrilled to introduce the groundbreaking strategies formulated by its freshly appointed Treasurer and Director, Mr [...]
Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment loss
26/06/2024
Bagsværd, Denmark, 26 June 2024 – Novo Nordisk today announced that the CLARION-CKD phase 3 trial failed to meet its primary endpoint and that it will recognise an impairment loss of around DKK 5.7 billion related to [...]
COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
26/06/2024
Former Horizon Therapeutics CEO adds valuable expertise in the discovery, development, and commercialization of treatments for autoimmune and inflammatory diseases CHICAGO, June 26, 2024 (GLOBE NEWSWIRE) -- COUR [...]
Safety Shot Partners with Atlantic Beverage Distributors to Expand Distribution Into Massachusetts and Rhode Island
26/06/2024
This Partnership Marks the Next Step in the Company’s Expansion Plan in the Northeast JUPITER, FL, June 26, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc . (Nasdaq: SHOT) (the “Company), announced today its strategic [...]
Positron Corporation Orders 5 NeuSight PET-CT Scanners for US Market
26/06/2024
Niagara Falls, NY, June 26, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission [...]
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions
26/06/2024
Lengthens Patent Exclusivity of Plogosertib until August 2040 BERKELEY HEIGHTS, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a [...]
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
26/06/2024
DALLAS, June 26, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic [...]
Ocean Spray and Brightseed Expand Partnership to Validate Novel Health Benefits Of Bioactive Compounds Found In Various Cranberry Varieties Using Forager® AI
26/06/2024
The companies’ latest research findings that demonstrate cranberries’ hidden health potential to be presented in a poster session at NUTRITION 2024 SAN FRANCISCO, June 26, 2024 (GLOBE NEWSWIRE) -- Brightseed , the [...]
Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal
26/06/2024
Study demonstrates strong statistical separation between patients receiving Nexalin’s DIFS® technology in combination with escitalopram (Lexapro) vs sham group receiving escitalopram alone Two-thirds of patients [...]
Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO
26/06/2024
The AlterG NEO combines updated user-friendly design with trusted Anti-Gravity technology for precise and consistent unweighting in physical rehabilitation and athletic training Updated features and a cost-effective [...]
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
26/06/2024
Study published in peer-reviewed journal finds BioStem’s products offer overall better treatment efficiency, and greater efficiency in general wound closure POMPANO BEACH, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- BioStem [...]
Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
26/06/2024
AXA is the 2 nd Largest Provider of Private Medical Insurance in the UK Payer Coverage is the Most Important Catalyst Aclarion can Achieve to Drive Volume and Revenue AXA Represents the First Insurance Company to [...]

Pages